Rising Drug Costs: Are Pharmacy Benefits Managers to Blame?
More news - Breaking news For many Americans, the rising tide of prescription drug prices seems like an unstoppable force, threatening to drown family budgets and access to health care. While pharmaceutical companies often shoulder the brunt of public blame, the web of influences on drug costs is much more intricate. Today, we shine a spotlight on a critical, but usually hidden, player in this system: pharmacy benefit managers, or PBMs. Rebecca Robbins, a leading investigative journalist specializing in pharmaceuticals for the New York Times, will take us on a deep dive into the world of PBMs. We will explore…







